학술논문

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease
Document Type
Article
Source
In: Cell Metabolism. (Cell Metabolism, 1 March 2022, 34(3):396-407.e6)
Subject
Language
English
ISSN
19327420
15504131